Recto, Rudita .
HRN: 14-79-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2023
CEFTRIAXONE 1G (VIAL)
07/27/2023
08/03/2023
IV
2g
Q24h
Cap-hr, T/c Septic Encephalopathy From Cap-hr, S/p Cvd Infarct
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes